Helius Medical Technologies, Inc. provided revenue guidance for the first quarter of 2022. For the period, the company expects revenue to range from $150,000 to $170,000 and quarterly revenue to increase sequentially each quarter throughout the year as the U.S. commercialization of PoNS develops.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | -6.43% | +5.65% | -83.70% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.70% | 4.15M | |
+7.32% | 217B | |
+13.83% | 194B | |
+20.48% | 143B | |
+31.33% | 111B | |
+3.08% | 64.3B | |
+14.64% | 52.94B | |
+2.72% | 49.53B | |
-5.88% | 38.31B | |
+0.25% | 35.22B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Provides Revenue Guidance for the First Quarter of 2022